The lab will offer arrayed CRISPR screening for chronic disease through collaborations with researchers from across the U.K.

Astrazeneca plc is investing heavily in China, signing two R&D deals, worth up to about $8 billion in up-front payments and ...

Merck joins a growing list of companies targeting lipoprotein(a), high levels of which are associated with an elevated risk ...

ELRIG, a not-for-profit, volunteer-led organization for the drug discovery community, today announced the keynote speakers for Therapeutic Oligonucleotides 2025 taking place at the AstraZeneca R&D ...

The PMCPA has dug into the industry’s LinkedIn activities once again. | The PMCPA has dug into the industry’s LinkedIn activities once again. AstraZeneca received the harshest censure in the latest ...

Multinational pharmaceutical company AstraZeneca is bullish about China's role as a global innovation powerhouse, underpinned ...

Beijing assures US and other foreign business leaders that it will continue to open its market to investments and ...

The veteran NFL sportscaster Erin Andrews has got her fans worried after opening up about her very hard personal life struggles.

Building upon its already impressive obesity drug portfolio, Novo Nordisk A/S has licensed a triple agonist of the receptors for GLP-1, GIP and glucagon from United Biotechnology Co. Ltd. China-based ...

Assemblin has been tasked with an upgrade of AstraZeneca’s Gärtuna production plant in Södertälje, Sweden. The project ...

Philanthropies, especially from venture-minded or justice-driven donors, could step in where policy has stalled. By funding ...

The investments come amid an ongoing investment fraud probe into AstraZeneca’s former China head Leon Wang—and despite ...